These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31238251)

  • 21. Radioiodine Labeling Reagents and Methods for New Chemical Entities and Biomolecules.
    Kumar K
    Cancer Biother Radiopharm; 2022 Apr; 37(3):173-185. PubMed ID: 34767725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Criteria for the design and biological characterization of radiolabeled peptide-based pharmaceuticals.
    Benedetti E; Morelli G; Accardo A; Mansi R; Tesauro D; Aloj L
    BioDrugs; 2004; 18(5):279-95. PubMed ID: 15377171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical and clinical studies of peptide receptor radionuclide therapy.
    Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
    Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of radioiodine in nuclear medicine-A brief overview.
    Ferris T; Carroll L; Jenner S; Aboagye EO
    J Labelled Comp Radiopharm; 2021 Mar; 64(3):92-108. PubMed ID: 33091159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-based radiopharmaceuticals for targeted tumor therapy.
    Dong C; Liu Z; Wang F
    Curr Med Chem; 2014; 21(1):139-52. PubMed ID: 23992337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
    Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
    Behr TM; Béhé M; Becker W
    Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabelled regulatory peptides for imaging and therapy.
    Breeman WA; Kwekkeboom DJ; de Blois E; de Jong M; Visser TJ; Krenning EP
    Anticancer Agents Med Chem; 2007 May; 7(3):345-57. PubMed ID: 17504160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment.
    Maecke HR; Reubi JC
    J Nucl Med; 2011 Jun; 52(6):841-4. PubMed ID: 21571797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
    Giblin MF; Veerendra B; Smith CJ
    In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of radioiodinated ethopabate as a potential tumor targeting agent.
    Aboumanei MH; Mahmoud AF; Motaleb MA
    Appl Radiat Isot; 2022 Feb; 180():110063. PubMed ID: 34922310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted radionuclide therapy for lung cancer with iodine-131-labeled peptide in a nude-mouse model.
    Chen Z; Gao H; Li M; Fang S; Li G; Guo L
    Anticancer Drugs; 2017 Jun; 28(5):480-488. PubMed ID: 28379897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
    Ginj M; Zhang H; Eisenwiener KP; Wild D; Schulz S; Rink H; Cescato R; Reubi JC; Maecke HR
    Clin Cancer Res; 2008 Apr; 14(7):2019-27. PubMed ID: 18381940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-targeting conjugates designed to improve the efficacy of radiolabeled peptides.
    Kluba CA; Bauman A; Valverde IE; Vomstein S; Mindt TL
    Org Biomol Chem; 2012 Oct; 10(37):7594-602. PubMed ID: 22898743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioiodination of BODIPY and its application to a nuclear and optical dual functional labeling agent for proteins and peptides.
    Ono M; Watanabe H; Ikehata Y; Ding N; Yoshimura M; Sano K; Saji H
    Sci Rep; 2017 Jun; 7(1):3337. PubMed ID: 28611426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide radiopharmaceuticals for diagnosis and therapy.
    Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
    Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-targeted diagnostics and radiotherapeutics.
    Tweedle MF
    Acc Chem Res; 2009 Jul; 42(7):958-68. PubMed ID: 19552403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
    Okarvi SM
    Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
    Sosabowsky J; Melendez-Alafort L; Mather S
    Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.